| Thursday, Nov 19, 2026 | |||
|---|---|---|---|
| Hall A | Hall B | ||
| 13:00-17:30 | Hands-on Workshop on Preparation of Ovarian Tissue for Cryopreservation Chairs: Debra Gook, Australia and Claus Yding Andersen, Denmark |
13:00-17:30 | Oncofertility 101 |
| 13:00-13:10 | Welcome and Introduction to Oncofertility Molly Moravek, Henry Ford Health, MI, USA |
||
| 13:10-13:55 | Female Fertility Preservation Molly Moravek, Henry Ford Health, MI, USA |
||
| 13:55-14:40 | Male Fertility Preservation James Smith, UCSF, CA, USA |
||
| 14:40-15:25 | Pediatric Fertility Preservation Tyler Ketterl, University of Washington, WA, USA |
||
| 15:25-15:40 | Break | ||
| 15:40-16:25 | Effective Patient Navigation Kristin Smith, BS, Northwestern Medicine, IL, USA |
||
| 16:25-17:30 | How to Build a Comprehensive Fertility Preservation Program Joseph Letourneau and Douglas Fair, University of Utah, UT, USA |
||
| 17:30-18:30 | Technical break | ||
| 18:30-18:45 | Inauguration of the Conference Claus Yding Andersen, Denmark and Pasquale Patrizio, USA |
||
| 18:45-19:15 | Honorary Lecture 1 Chairs: Pasquale Patrizio, USA and Glenn Schattman, USA Ovarian cancer/Endometriosis: new treatment models Alan Trounson, Australia |
||
| 19:15 | Welcome Reception | ||
| Friday, Nov 20, 2026 | |||
|---|---|---|---|
| Hall A | Hall B | ||
| 08:30-09:00 | Honorary Lecture 2 Chair: Claus Yding Andersen, Denmark Perspectives on fertility preservation in cancer patients: How to balance an urgent need for treatment and desire to reproduce Hamish Wallace, UK |
||
| 09:00-10:15 | Session 1A: Cancer therapy and fertility preservation Chairs: Marie-Madeleine Dolmans, Belgium and Zev Rosenwaks, USA |
09:00-10:15 | Session 1B: New and experimental approaches in fertility preservation Chairs: Pasquale Patrizio, USA and Jung Ryeol Lee, Korea |
| 09:00-09:20 | Novel and upcoming cancer therapies: are they gonadotoxic? Roy Herbst, USA |
09:00-09:20 | Ovarian tissue freezing for fertility preservation in patients with hemoglobin disorders Rebecca Flyckt, USA |
| 09:20-09:40 | Impact of new antibody-based cancer treatments on fertility Karla Hutt, Australia |
09:20-09:40 | Freeze both ovaries in connection with bone marrow transplantation? – Pro and con Catherine Poirot, France |
| 09:40-10:00 | Impact of the new anticancer therapies on the chances and outcomes of future pregnancies Ann Partridge, USA |
09:40-10:00 | Breakthroughs in fertility preservation: innovative approaches for immediate and long-term care Amir Arav, Israel |
| 10:00-10:15 | Q&A | 10:00-10:15 | Q&A |
| 10:15-10:45 | Coffee Break | ||
| 10:45-12:00 | Session 2A: Ovarian Protection and Mechanisms of Gonadotoxicity Chairs: Jacquez Donnez, Belgium and Nalini Kaul Mahajan, India |
10:45-12:00 | Session 2B: Expanding fertility preservation and impact of new cancer treatments Chairs: Kristin Smith, USA and Matteo Lambertini, Italy |
| 10:45-11:05 | DNA damage and repair in the preantral follicle pool following radiotherapy Luciana Cacciottola, Belgium |
10:45-11:05 | Biological mechanisms of treatment-induced gonadotoxicity with the new anticancer therapies Isabelle Demeestere, Belgium |
| 11:05-11:25 | Insights gained from studies investigating chemotherapy effects on the ovaries Dror Meirow, Israel |
11:05-11:25 | Preserving versus restoring fertility-restorative reproductive medicine is not enough Terri Woodard, USA |
| 11:25-11:45 | Gonadoprotection against chemotherapy, the challenge of the future Marie-Madeleine Dolmans, Belgium |
11:25-11:45 | How to expand coverage of fertility preservation: how to approach legislators and inclusion of patients Joyce Reinecke, USA |
| 11:45-12:00 | Q&A | 11:45-12:00 | Q&A |
| 12:00-13:15 | Session 3A: Fertility preservation with Ovarian Malignancy Chairs: Abed Sinno, USA and Nao Suzuki, Japan |
12:00-13:15 | Session 3B: Oral Session of selected posters Chairs: Debra Gook, Australia & Molly Moravek, USA |
| 12:00-12:20 | Ex-vivo retrievals for patients with ovarian malignancy: How to coordinate treatment Glenn Schattman, USA |
12:00-12:15 | Oral presentation 1 |
| 12:20-12:45 | Fertility preservation in borderline ovarian tumors; what if the contralateral ovary is ok? Nao Suzuki, Japan |
12:15-12:30 | Oral presentation 2 |
| 12:45-13:05 | Patients undergoing cystectomy: Safety of stimulation? Ozgur Oktem, Turkey |
12:30-12:45 | Oral presentation 3 |
| 13:05-13:20 | Q&A | 12:45-13:00 | Oral presentation 4 |
| 13:00-13:20 | Q&A | ||
| 13:20-14:00 | Lunch | ||
| Oncology afternoon | |||
| 14:00-15:15 | Session 4A: Fertility Preservation Hematological and Gynecological Cancers (Sylvester Cancer Center) Chairs: Stephen Nimer, USA and Pasquale Patrizio, USA |
14:00-15:15 | Session 4B: Fertility Preservation in boys Chairs: Kyle Orwig, USA and Rod Mitchell, UK |
| 14:00-14:20 | Genetic markers and therapeutic solutions for leukemia Stephen Nimer, USA |
14:00-14:20 | Indications – genetic conditions – cryptorchidism – cancer Emilie Johnson, USA |
| 14:20-14:40 | Ovarian tissue transplantation in acute leukemia: balancing the risk of relapse and the hope of parenthood Florian Chevillon, France |
14:20-14:40 | Experience with transplantation of prepubertal human testicular tissue Ellen Goossens, Belgium |
| 14:40-15:00 | Fertility preservation in cervical cancer Abed Sinno, USA |
14:40-15:00 | Obtaining chromosomal normal spermatogonial stem cells in Klinefelter Syndrome patients Hooman Sadri-Ardekani, USA |
| 15:00-15:15 | Q&A | 15:00-15:15 | Q&A |
| 15:15-16:30 | Session 5A: Oncology-Breast Cancer patients and Fertility Preservation Chairs: Carmen Calfa, USA and Matteo Lambertini, Italy |
15:15-16:30 | Session 5B: In Vitro Maturation of Human Oocytes in connection with freezing ovarian tissue Chairs: Liang Xiaoyan, China and Jesus Cadenas, Denmark |
| 15:15-15:35 | Update on efficacy and safety of fertility preservation in patients with breast cancer Moran Shapira, Israel |
15:15-15:35 | IVM experience from Vietnam Ho Tuong, Vietnam |
| 15:35-15:55 | Oncologic and reproductive outcomes after fertility preservation in women with breast cancer – the needed long-term observation time Kenny Rodriguez-Wallberg, Sweden |
15:35-15:55 | IVM in connection with OTC – experience from China Liang Xiaoyan, China |
| 15:55-16:15 | Safety of pregnancy after breast cancer: what is current evidence Matteo Lambertini, Italy |
15:55-16:15 | Techniques for aspiration of human small antral follicles (2–5 mm) without general anesthesia Kristine Løssl, Denmark |
| 16:15-16:30 | Q&A | 16:15-16:30 | Q&A |
| 16:30-16:45 | Coffee Break | ||
| 16:45-18:00 | Session 6A: Testicular Tissue Cryopreservation: Fertility preservation Chairs: Ellen Goossens, Belgium and Hooman Sadri-Ardekani, USA |
16:45-18:00 | Session 6B: Understanding human folliculogenesis Chairs: Debra Gook, Australia and TBA |
| 16:45-17:05 | Worldwide activity – amount of tissue frozen – methods Rod Mitchell, UK | 16:45-17:05 | Engineering strategies for the follicular micro-environment Monica Laronda, USA |
| 17:05-17:25 | Surgical experience and outcome of transplanting adult human testicular tissue TBA |
17:05-17:25 | Update on progress of human in vitro follicle activation – any clinical solutions in sight? David Albertini, USA |
| 17:25-17:45 | New aspects of testicular tissue freezing: Does the intratubular milieu only allow other than spermatogonia stem cells to implant? Kyle Orwig, USA |
17:25-17:45 | New drugs/agonists to prevent or initiate initiation of follicular growth (AMH, GDF9, others) Laura Detti, USA |
| 17:45-18:00 | Q&A | 17:45-18:00 | Q&A |
| 19:00-22:00 | Social Event | ||
| Saturday, Nov 21, 2026 | |||
|---|---|---|---|
| Hall A | Hall B | ||
| 08:30-09:00 | Honorary Lecture 3: Chairs: Dror Meirow, Israel and Claus Yding Andersen, Denmark Current status and potential for creating human artificial gametes Amander Clark, USA |
||
| 09:00-10:15 | Session 7A: Ovarian Tissue Cryopreservation in Children and Adolescents Chairs: Kenny Rodriguez-Wallberg, Sweden and Hamish Wallace, UK |
09:00-10:15 | Session 7B: AI in fertility preservation Chairs: Pasquale Patrizio, USA and Jung Ryeol Lee, Korea |
| 09:00-09:20 | Indications and worldwide activity of fertility preservation in prepubertal girls Elizabeth Ginsburg, USA |
09:00-09:20 | Prediction of outcomes from oocytes and sperm to improve counseling Charles Bormann, USA |
| 09:20-09:40 | Fertility preservation in girls, OTC and OTT in girls with thalassemia and sickle cell anemia Liang Xiaoyan, China |
09:20-09:40 | Use of AI and robotics combined with microscopy-/ultrasound to select for strips of the most follicle-rich tissue in procurement of ovarian tissue Ariella Shikanov, USA |
| 09:40-10:00 | Freezing ovarian tissue from young prepubertal girls – technical aspects Claus Yding Andersen, Denmark |
09:40-10:00 | Novel fertility preservation approaches using stem cells and exosomes Ayman Al-Handy, USA |
| 10:00-10:15 | Q&A | 10:00-10:15 | Q&A |
| 10:15-10:45 | Coffee Break | ||
| 10:45-12:00 | Session 8A: Ovarian Tissue Transplantation Chairs: Nao Suzuki, Japan and Dror Meirow, Israel |
10:45-12:00 | Session 8B: Oral Session of selected posters Chairs: Monica Laronda, USA and Kristin Smith, USA |
| 10:45-11:05 | Ovarian tissue transplantation: Worldwide activity, results, and recurrence Michael von Wolff, Switzerland |
10:45-11:00 | Oral presentation 1 |
| 11:05-11:25 | Which site to transplant – does ovulation occur from the peritoneal pocket positioned tissue? Isabelle Demeestere, Belgium |
11:00-11:15 | Oral presentation 2 |
| 11:25-11:45 | Allogenic transplantation of ovarian tissue-update Sherman Silber, USA |
11:15-11:30 | Oral presentation 3 |
| 11:45-12:00 | Q&A | 11:30-11:45 | Oral presentation 4 |
| 11:45-12:00 | Q&A | ||
| 12:00-13:15 | Session 9A: Longevity of ovarian function Chairs: Glenn Schattman, USA and Jung Ryeol Lee, Korea |
12:00-13:15 | Session 9B: Oral Session of selected posters Chairs: Claus Yding Andersen, Denmark and Zev Rosenwaks, USA |
| 12:00-12:20 | Predictive markers for longevity of transplanted ovarian tissue – beyond age Debra Gook, Australia |
12:00-12:15 | Oral presentation 1 |
| 12:20-12:45 | Ex vivo ovarian perfusion: Folliculogenesis and oocyte retrievals after gonadotropins Pasquale Patrizio, USA |
12:15-12:30 | Oral presentation 2 |
| 12:45-13:05 | Understanding molecular mechanism of freeze-thaw injury after OTC and oocyte cryopreservation and how to improve preservation Wen Li, China |
12:30-12:45 | Oral presentation 3 |
| 13:05-13:20 | Q&A | 12:45-13:00 | Oral presentation 4 |
| 13:00-13:20 | Q&A | ||
| 13:20-14:00 | Lunch (potentially a company sponsored symposium) | ||
| 14:00-15:15 | Session 10A: Artificial Ovaries, artificial follicle formation, gonadal IPSc Chairs: Debra Gook, Australia and Monica Laronda, USA |
14:00-15:15 | Session 10B: Oncology and endometriosis Chairs: Kenny Rodriguez-Wallberg, Sweden and Jacquez Donnes, Belgium |
| 14:00-14:20 | Restoring steroidogenesis using hPSC-derived GPCs-initially for securing endocrine function after menopause? Daylon James, USA |
14:00-14:20 | Hormonal replacement strategies in survivors of Gynecological cancers Abed Sinno, USA |
| 14:20-14:40 | In vitro folliculogenesis from human IPSCs Katsuhiko Hayashi, Japan |
14:20-14:40 | Ovarian tissue cryopreservation and fertility preservation in endometriosis Zaraq Khan, USA |
| 14:40-15:00 | Artificial ovaries for fertility and hormone therapy Jung Ryeol Lee, Korea |
14:40-15:00 | Use of letrozole in ovarian stimulation for fertility preservation in women with estrogen sensitive tumors. Current evolution and therapeutic approaches to breast cancer Carmen Calfa, USA |
| 15:00-15:15 | Q&A | 15:00-15:15 | Q&A |
| 15:15-16:30 | Session 11A: Fertility Preservation in Endometriosis and Uterus Surgery Chairs: Tommaso Falcone, USA and Nao Suzuki, Japan |
15:15-16:30 | Session 11B: Oral Session of selected posters Chairs: Marie-Madeleine Dolmans, Belgium and Terri Woodard, USA |
| 15:15-15:35 | Uterus transplantation: An update Mats Brännström, Sweden |
15:15-15:30 | Oral presentation 1 |
| 15:35-15:55 | Uterine surgery to preserve fertility through uterus conservation in fibromyomatosis/ adenomyosis Tommaso Falcone, USA |
15:30-15:45 | Oral presentation 2 |
| 15:55-16:15 | Uterus preservation for fertility conservation Jacques Donnez, Belgium |
15:45-16:00 | Oral presentation 3 |
| 16:15-16:30 | Q&A | 16:00-16:15 | Oral presentation 4 |
| 16:15-16:30 | Q&A | ||
| 16:30-16:45 | Coffee Break | ||
| 16:45-18:00 | Session 12A: Cancer survivorship-Sylvester cancer center Chairs: Hamish Wallace, UK and Roy Herbst, USA |
16:45-18:00 | Session 12B: Understanding IVM Chairs: Tuong H, Vietnam and Claus Yding Andersen, Denmark |
| 16:45-17:05 | Supporting the reproductive health of adolescent girls who are pediatric cancer survivors Judy Simms-Cendan, USA |
16:45-17:05 | How does CAPA-IVM work and is there other solutions to optimize oocyte maturation Ri-Cheng Chian, China |
| 17:05-17:25 | Cancer survivorship: enhancing well-being beyond cancer treatment Frank Penedo, USA |
17:05-17:25 | Two for one: Combining OTC with IVM from medullary antral follicles: results of combined approaches in Denmark Jesus Cadenas, Denmark |
| 17:25-17:45 | Harnessing circadian biology to optimize cancer treatment response Tracy Crane, USA |
17:25-17:45 | Does co-culture of hIPS cell-derived ovarian support cells improve IVM? Christian Kramme, USA |
| 17:45-18:00 | Q&A | 17:45-18:00 | Q&A |
| 18:00-18:30 | Adjourn and Closing Ceremony | ||
